Delivery Order SPE2DB22D2006-SPE2DB25FW2VJ
- Not listed
- The Defense Logistics Agency awarded a $2,117.00 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,743.48 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/ml. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by August 27, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,416 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, awarded September 12, 2025, represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,190.08 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed price, non-set-aside contract was awarded on July 15, 2025, with an ultimate completion date of July 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,019.16 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on April 22, 2025, with an ultimate completion date of April 23, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,460.46 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child contract under...
- This delivery order, awarded August 29, 2025, grants AmerisourceBergen Drug Corp a $1,449.00 firm fixed price contract for Testosterone Cypionate 200 mg/mL, with completion scheduled for September 2, 2025. The award was issued by the Defense Logistics Agency under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,619.00 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, competitively awarded delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. AmerisourceBergen will perform this contract from its corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a $3,040.02 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a competitively awarded, firm fixed price contract with no set-aside designation. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2VJDelivery Order
The Defense Logistics Agency awarded a $1,786.65 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to military and veteran healthcare systems. This delivery order exemplifies the company's role in fulfilling hormone treatment requirements across the DLA's pharmaceutical supply chain, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. The contract reflects the company's capability to meet federal procurement requirements through open competition and demonstrates its versatility in handling both high-value and smaller medical supply transactions across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/25/25 |